NCT01400932View on ClinicalTrials.gov

Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Acne Vulgaris
Interventions
DRUG

GI148512

GI148512, Topical gel in 1 g containing benzoyl peroxide 30 mg

DRUG

vehicle gel

Matching vehicle gel of GI148512, not containing active ingredient (benzoyl peroxide)

Trial Locations (19)

215-0036

GSK Investigational Site, Kanagawa

220-0004

GSK Investigational Site, Kanagawa

224-0001

GSK Investigational Site, Kanagawa

234-0051

GSK Investigational Site, Kanagawa

240-0013

GSK Investigational Site, Kanagawa

242-0007

GSK Investigational Site, Kanagawa

530-6012

GSK Investigational Site, Osaka

554-0021

GSK Investigational Site, Osaka

332-0031

GSK Investigational Site, Saitama

102-0072

GSK Investigational Site, Tokyo

107-0062

GSK Investigational Site, Tokyo

116-0003

GSK Investigational Site, Tokyo

150-0047

GSK Investigational Site, Tokyo

157-0071

GSK Investigational Site, Tokyo

169-0075

GSK Investigational Site, Tokyo

180-0004

GSK Investigational Site, Tokyo

180-0023

GSK Investigational Site, Tokyo

190-0023

GSK Investigational Site, Tokyo

195-0053

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01400932 - Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects | Biotech Hunter | Biotech Hunter